Cross-source evidence timeline
Pegcetacoplan research timeline
Follow 51 selected, directly cited source records from October 6, 2020 through November 13, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Literature metadata
Pegcetacoplan in C3 Glomerulopathy and Primary Immune-Complex MPGN.↗
PubMed lists PMID 43024395 in Journal of the American Society of Nephrology : JASN as Journal Article, with publication-date metadata of 2026-11-13 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 13, 2026 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06722157↗
PeptideScanner retained ClinicalTrials.gov record NCT06722157 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT03531255↗
PeptideScanner retained ClinicalTrials.gov record NCT03531255 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Literature metadata
Pegcetacoplan for geographic atrophy: Bridging the "clinical relevance gap" through precision medicine.↗
PubMed lists PMID 42998772 in Survey of ophthalmology as Journal Article, Review, with publication-date metadata of 2026-11-07 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 7, 2026 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07898774↗
PeptideScanner retained ClinicalTrials.gov record NCT07898774 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Literature metadata
Mixed Intravascular and Extravascular Hemolysis Despite Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case of Switching to Pegcetacoplan.↗
PubMed lists PMID 42972953 in Turkish journal of haematology : official journal of Turkish Society of Haematology as Journal Article, with publication-date metadata of 2026-11-03 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 3, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Temporal, Phenotypic, and Treatment-Context Heterogeneity in Retinal Vasculitis Reporting with Pegcetacoplan: A United States Pharmacovigilance Study.↗
PubMed lists PMID 42930807 in Journal of personalized medicine as Journal Article, with publication-date metadata of 2026-10-16 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 16, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Distinct Pharmacodynamic Complement Biomarker Signatures Define Iptacopan and Pegcetacoplan Treatment in C3 Glomerulopathy.↗
PubMed lists PMID 42898424 in Kidney international reports as Journal Article, with publication-date metadata of 2026-09-18 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 18, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Podocyte and tubular vacuolization in patients receiving pegcetacoplan.↗
PubMed lists PMID 42800616 in Kidney international as Case Reports, Journal Article, with publication-date metadata of 2026-09-26 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 26, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Pharmacokinetic/pharmacodynamic analysis of geographic atrophy lesion area in patients receiving pegcetacoplan treatment or sham.↗
PubMed lists PMID 39497616 in CPT: pharmacometrics & systems pharmacology as Clinical Trial, Phase II, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2024-11-05 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 5, 2024 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07746895↗
PeptideScanner retained ClinicalTrials.gov record NCT07746895 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05776472↗
PeptideScanner retained ClinicalTrials.gov record NCT05776472 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-09-03, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Literature metadata
Pegcetacoplan: the first and only C3-targeted therapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria.↗
PubMed lists PMID 39656072 in Expert review of hematology as Journal Article, Review, with publication-date metadata of 2024-12-16 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 16, 2024 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GN: Phase 3 VALIANT Subgroup Analysis.↗
PubMed lists PMID 42133432 in Clinical journal of the American Society of Nephrology : CJASN as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, Multicenter Study, with publication-date metadata of 2026-05-14 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 14, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Pegcetacoplan Treatment and Consensus Features of Geographic Atrophy Over 24 Months.↗
PubMed lists PMID 38722644 in JAMA ophthalmology as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2024-06-01 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 1, 2024 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons.↗
PubMed lists PMID 42138781 in Advances in therapy as Clinical Trial, Phase III, Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2026-05-15 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 15, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Dynamics of the EZ/RPE Loss Ratio on OCT Over Time During Geographic Atrophy Progression and Treatment With Pegcetacoplan.↗
PubMed lists PMID 40833323 in Investigative ophthalmology & visual science as Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-08-01 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 1, 2025 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07214298↗
PeptideScanner retained ClinicalTrials.gov record NCT07214298 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-08-19, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Literature metadata
Direct Switch From Iptacopan to Pegcetacoplan in a Patient With Paroxysmal Nocturnal Hemoglobinuria.↗
PubMed lists PMID 42022788 in EJHaem as Journal Article, with publication-date metadata of 2026-04-21 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 21, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Pegcetacoplan prophylaxis for recurrent C3 glomerulopathy with multifactorial genetic background.↗
PubMed lists PMID 42061561 in Kidney international as Case Reports, Journal Article, with publication-date metadata of 2026-04-28 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 28, 2026 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07160179↗
PeptideScanner retained ClinicalTrials.gov record NCT07160179 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-07-13, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT04901936↗
PeptideScanner retained ClinicalTrials.gov record NCT04901936 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-06-26, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06161584↗
PeptideScanner retained ClinicalTrials.gov record NCT06161584 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-06-01, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07495722↗
PeptideScanner retained ClinicalTrials.gov record NCT07495722 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-04-29, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT04572854↗
PeptideScanner retained ClinicalTrials.gov record NCT04572854 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-04-21, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05809531↗
PeptideScanner retained ClinicalTrials.gov record NCT05809531 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-04-02, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT04919629↗
PeptideScanner retained ClinicalTrials.gov record NCT04919629 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-03-23, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Literature metadata
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.↗
PubMed lists PMID 41337715 in The New England journal of medicine as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, Multicenter Study, with publication-date metadata of 2025-12-04 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 4, 2025 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05067127↗
PeptideScanner retained ClinicalTrials.gov record NCT05067127 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-01-29, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Literature metadata
Fatigue and health-related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analysis of the pegcetacoplan PEGASUS trial data.↗
PubMed lists PMID 36965105 in European journal of haematology as Clinical Trial, Phase III, Journal Article, with publication-date metadata of 2023-04-19 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 19, 2023 · day precisionAdded to PeptideScanner November 16, 2026
Source year
2025
Clinical trials
ClinicalTrials.gov record NCT05148299↗
PeptideScanner retained ClinicalTrials.gov record NCT05148299 at 2026-11-16T01:37:14.654Z. Its registry update date was 2025-11-28, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05096403↗
PeptideScanner retained ClinicalTrials.gov record NCT05096403 at 2026-11-16T01:37:14.654Z. Its registry update date was 2025-10-30, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Literature metadata
Treatment of geographic atrophy: an update on data related to pegcetacoplan.↗
PubMed lists PMID 37815317 in Current opinion in ophthalmology as Review, Journal Article, with publication-date metadata of 2023-10-10 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 10, 2023 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE.↗
PubMed lists PMID 40280279 in American journal of ophthalmology as Journal Article, Clinical Trial, Phase III, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2025-04-23 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 23, 2025 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Normalization of Hemoglobin, Lactate Dehydrogenase, and Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan.↗
PubMed lists PMID 38727860 in Drugs in R&D as Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, with publication-date metadata of 2024-05-10 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 10, 2024 · day precisionAdded to PeptideScanner November 16, 2026
Source year
2024
Literature metadata
Hemolysis events in the phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria.↗
PubMed lists PMID 38593241 in Blood advances as Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-06-11 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 11, 2024 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplan.↗
PubMed lists PMID 38453703 in Annals of hematology as Journal Article, Clinical Trial, with publication-date metadata of 2024-03-08 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 8, 2024 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function.↗
PubMed lists PMID 39201278 in International journal of molecular sciences as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2024-08-06 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 6, 2024 · day precisionAdded to PeptideScanner November 16, 2026
Source year
2023
Literature metadata
Advancements in the treatment of geographic atrophy: focus on pegcetacoplan in age-related macular degeneration.↗
PubMed lists PMID 38098608 in Annals of medicine and surgery (2012) as Journal Article, Review, with publication-date metadata of 2023-11-01 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 1, 2023 · day precisionAdded to PeptideScanner November 16, 2026Regulatory
Federal Register notice 2023-26255↗
The Federal Register published notice 2023-26255, attributed to FDA and its parent HHS department, on 2023-11-29. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; Empaveli,” and PeptideScanner's exact reviewed identity mapping connects the document to Pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Literature metadata
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.↗
PubMed lists PMID 37195551 in PharmacoEconomics - open as Journal Article, Review, with publication-date metadata of 2023-05-17 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 17, 2023 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT03525613↗
PeptideScanner retained ClinicalTrials.gov record NCT03525613 at 2026-11-16T01:37:14.654Z. Its registry update date was 2023-07-06, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Literature metadata
WITHDRAWN: Pegcetacoplan in the treatment of geographic atrophy.↗
PubMed lists PMID 37259853 in Immunotherapy as Journal Article, Review, with publication-date metadata of 2023-06-01 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 1, 2023 · day precisionAdded to PeptideScanner November 16, 2026Regulatory
Drugs@FDA application NDA217171↗
The official Drugs@FDA dataset lists original submission 1 for NDA 217171 with status AP dated 2023-02-17, and names pegcetacoplan among the application record's active ingredients.↗
Added to PeptideScanner November 16, 2026
Source year
2022
Clinical trials
ClinicalTrials.gov record NCT03500549↗
PeptideScanner retained ClinicalTrials.gov record NCT03500549 at 2026-11-16T01:37:14.654Z. Its registry update date was 2022-03-25, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026
Source year
2021
Regulatory
Drugs@FDA application NDA215014↗
The official Drugs@FDA dataset lists original submission 1 for NDA 215014 with status AP dated 2021-05-14, and names pegcetacoplan among the application record's active ingredients.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02588833↗
PeptideScanner retained ClinicalTrials.gov record NCT02588833 at 2026-11-16T01:37:14.654Z. Its registry update date was 2021-01-11, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02264639↗
PeptideScanner retained ClinicalTrials.gov record NCT02264639 at 2026-11-16T01:37:14.654Z. Its registry update date was 2021-01-08, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026
Source year
2020
Clinical trials
ClinicalTrials.gov record NCT03593200↗
PeptideScanner retained ClinicalTrials.gov record NCT03593200 at 2026-11-16T01:37:14.654Z. Its registry update date was 2020-12-22, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02461771↗
PeptideScanner retained ClinicalTrials.gov record NCT02461771 at 2026-11-16T01:37:14.654Z. Its registry update date was 2020-10-06, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02503332↗
PeptideScanner retained ClinicalTrials.gov record NCT02503332 at 2026-11-16T01:37:14.654Z. Its registry update date was 2020-10-06, and PeptideScanner's reviewed identity mapping was pegcetacoplan.↗
Added to PeptideScanner November 16, 2026